MedKoo Cat#: 561068 | Name: Napitane Mesylate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Napitane Mesylate, also known as ABT-200 or A-75200, is a potent alpha 2-adrenoceptor antagonist. Napitane Mesylate binds to CA transporters in the central nervous system and blocks uptake. Napitane Mesylate also blocks norepinephrine uptake by inhibiting the norepinephrine transporter.

Chemical Structure

Napitane Mesylate
Napitane Mesylate
CAS#149189-73-1 (mesylate)

Theoretical Analysis

MedKoo Cat#: 561068

Name: Napitane Mesylate

CAS#: 149189-73-1 (mesylate)

Chemical Formula: C23H29NO5S

Exact Mass:

Molecular Weight: 431.55

Elemental Analysis: C, 64.01; H, 6.77; N, 3.25; O, 18.54; S, 7.43

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
148152-63-0 (free base) 149189-73-1 (mesylate)
Synonym
Napitane Mesylate; ABT-200; A-75200
IUPAC/Chemical Name
(1'R*,3R*)-3-Phenyl-1- [(1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-naphthalenyl) methyl] pyrrolidine methanesulfonate
InChi Key
IXLOGUKQFISQPX-APTPAJQOSA-N
InChi Code
InChI=1S/C22H25NO2.CH4O3S/c1-2-5-16(6-3-1)17-11-12-23(13-17)14-18-7-4-8-20-19(18)9-10-21-22(20)25-15-24-21;1-5(2,3)4/h1-3,5-6,9-10,17-18H,4,7-8,11-15H2;1H3,(H,2,3,4)/t17-,18-;/m0./s1
SMILES Code
CS(=O)(O)=O.N1(C[C@@H]2CCCC3=C2C=CC4=C3OCO4)C[C@@H](C5=CC=CC=C5)CC1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 431.55 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Cass WA, Friedemann MN, deBernardis JF, Kerkman DJ, Gerhardt GA. Effects of the putative antidepressant, ABT 200, on the clearance of exogenous norepinephrine in rat cerebellum. Synapse. 1995 Sep;21(1):77-84. PubMed PMID: 8525465. 2: Firestone JA, Marks MJ, Gerhardt GA, Browning MD. ABT-200, a norepinephrine uptake inhibitor, blocks Ca2+ signals in chromaffin cells. Eur J Pharmacol. 1994 Oct 14;269(2):177-82. PubMed PMID: 7851493. 3: Hancock AA, Buckner SA, Giardina WJ, Brune ME, Lee JY, Morse PA, Oheim KW, Stanisic DS, Warner RB, Kerkman DJ, et al. Preclinical pharmacological actions of (+/-)-(1'R*,3R*)-3-phenyl-1- [1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200), a potential antidepressant agent that antagonizes alpha-2 adrenergic receptors and inhibits the neuronal uptake of norepinephrine. J Pharmacol Exp Ther. 1995 Mar;272(3):1160-9. PubMed PMID: 7891328. 4: Ferrero JL, Thomas SB, Marsh KC, Rodrigues AD, Uchic JT, Buko AM. Implication of P450-metabolite complex formation in the nonlinear pharmacokinetics and metabolic fate of (+/-)-(1'R*,3R*)-3-phenyl-1-[(1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-nap hthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200) in dogs. Drug Metab Dispos. 2002 Oct;30(10):1094-101. PubMed PMID: 12228185. 5: Magni LR, Purgato M, Gastaldon C, Papola D, Furukawa TA, Cipriani A, Barbui C. Fluoxetine versus other types of pharmacotherapy for depression. Cochrane Database Syst Rev. 2013 Jul 17;(7):CD004185. Review. PubMed PMID: 24353997. 6: Cipriani A, Brambilla P, Furukawa T, Geddes J, Gregis M, Hotopf M, Malvini L, Barbui C. Fluoxetine versus other types of pharmacotherapy for depression. Cochrane Database Syst Rev. 2005 Oct 19;(4):CD004185. Review. Update in: Cochrane Database Syst Rev. 2013;7:CD004185. PubMed PMID: 16235353; PubMed Central PMCID: PMC4163961. 7: Chen J, Rasenick MM. Chronic antidepressant treatment facilitates G protein activation of adenylyl cyclase without altering G protein content. J Pharmacol Exp Ther. 1995 Oct;275(1):509-17. PubMed PMID: 7562593.